20 to 50     : Dose as in normal renal function
10 to 20     : Dose as in normal renal function
<10           : Dose as in normal renal function
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in normal renal function
HD                     :Not dialysed. Dose as in normal renal function
HDF/high flux   :Not dialysed. Dose as in normal renal function
CAV/VVHD      :Unknown dialysability. Dose as in normal renal function
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs
Antibacterials: metabolism accelerated by rifamycins; metabolism possibly inhibited by erythromycin
Anticoagulants: efficacy of coumarins may be altered
Anti-epileptics: metabolism accelerated by carbamazepine, barbiturates, phenytoin and primidone
Antifungals: increased risk of hypokalaemia with amphotericin – avoid concomitant use; metabolism possibly inhibited by itraconazole and ketoconazole
Antivirals: concentration possibly increased by ritonavir
Ciclosporin: rare reports of convulsions in patients on ciclosporin and high-dose corticosteroids; increased levels of prednisolone; increased ciclosporin levels reported with prednisoloneCytotoxics: increased risk of haematological toxicity with methotrexate
Diuretics: enhanced hypokalaemic effects of acetazolamide, loop diuretics and thiazide diureticsVaccines: high dose corticosteroids can impair immune response to vaccines – avoid concomitant use with live vaccines
ADMINISTRATION
Reconstition
–
Route
Oral, IM, rectal
Rate of Administration
–
Comments
–
OTHER INFORMATION
Evidence of unpredictable bioavailability from enteric coated tablets – avoid if possible.